MetLife Inc
NYSE:MET
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
63.8177
88.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
MetLife Inc
Wall Street
Price Targets
MET Price Targets Summary
MetLife Inc
According to Wall Street analysts, the average 1-year price target for
MET
is 95.824 USD
with a low forecast of 81.81 USD and a high forecast of 106.05 USD.
MET Last Price Targets
MetLife Inc
The latest public price target was made on Oct 2, 2024 by
John Barnidge
from
Piper Sandler
,
who expects
MET
stock to
rise by 13%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
John Barnidge
Piper Sandler
|
92
USD
Upside 13% |
2 months ago
Oct 2, 2024
|
MetLife price target raised to $92 from $85 at Piper Sandler
TheFly
|
Alex Scott
Barclays
|
91
USD
Upside 12% |
3 months ago
Sep 4, 2024
|
Barclays Starts MetLife (MET) at Overweight
StreetInsider
|
Joshua Shanker
Bank of America Securities
|
96
USD
Upside 18% |
4 months ago
Aug 1, 2024
|
MetLife price target lowered to $96 from $99 at BofA
TheFly
|
Bob Huang
Morgan Stanley
|
83
USD
Upside 2% |
5 months ago
Jul 10, 2024
|
MetLife price target raised to $83 from $82 at Morgan Stanley
TheFly
|
Kevin Heal
Argus Research
|
80
USD
Downside 2% |
7 months ago
May 22, 2024
|
MetLife (MET) PT Raised to $80 at Argus
StreetInsider
|
|
John Barnidge
Piper Sandler
|
82
USD
Upside 1% |
7 months ago
May 6, 2024
|
MetLife (MET) PT Lowered to $82 at Piper Sandler
StreetInsider
|
Catherine Seifert
CFRA
|
77
USD
Downside 5% |
9 months ago
Mar 13, 2024
|
MetLife (MET) PT Raised to $77 at CFRA
StreetInsider
|
Alex Scott
Goldman Sachs
|
80
USD
Downside 2% |
11 months ago
Jan 8, 2024
|
Goldman Sachs Upgrades MetLife (MET) to Buy
StreetInsider
|
Brett Linzey
Mizuho Securities
|
145
USD
Upside 78% |
1 year ago
Sep 14, 2023
|
Marathon Oil To Rally Around 70%? Here Are 10 Other Analyst Forecasts For Thursday
Benzinga
|
|
Unknown Analyst
Morgan Stanley
|
90
USD
Upside 11% |
1 year ago
Feb 2, 2023
|
Morgan Stanley Maintains Overweight on MetLife, Raises Price Target to $90
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MET's stock price target?
Price Target
95.824
USD
According to Wall Street analysts, the average 1-year price target for
MET
is 95.824 USD
with a low forecast of 81.81 USD and a high forecast of 106.05 USD.
What is MetLife Inc's Revenue forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
MetLife Inc's revenue is
1%.
The projected
CAGR
for the next 4 years is
7%.
What is MetLife Inc's Net Income forecast?
Projected CAGR
56%
For the last 8 years the
compound annual growth rate for
MetLife Inc's net income is
-15%.
The projected
CAGR
for the next 4 years is
56%.
You don't have any saved screeners yet
